Shares of CME Group Inc. CME have gained 15.5% previously 12 months, outperforming the business‘s progress of 8.1%.
CME Group has outperformed its friends, together with Intercontinental Trade Inc. ICE, S&P World Inc. SPGI and OTC Markets Group Inc. OTCM. Shares of ICE and SPGI have gained 7.5% and 4.1%, respectively, whereas OTCM inventory has misplaced 4.4% previously 12 months.
Picture Supply: Zacks Funding Analysis
With a market capitalization of $98.71 billion, the common quantity of shares traded within the final three months was 1.9 million. CME has a strong observe document of beating earnings estimates in every of the final 4 quarters, with a mean of 1.82%.
CME Shares are Undervalued
CME Group shares are buying and selling at a reduction to the Zacks Securities and Trade business. Its ahead price-to-earnings of 23.61X is decrease than the business common of 23.83X.
Picture Supply: Zacks Funding Analysis
CME Buying and selling Above 50-Day and 200-Day Transferring Averages
Shares of CME Group closed at $273.74 on Wednesday and are buying and selling above the 50-day and 200-day easy transferring averages (SMA) of $271.90 and $270.71, respectively, indicating strong upward momentum. SMA is a broadly used technical evaluation instrument to foretell future worth developments by analyzing historic worth knowledge.
Picture Supply: Zacks Funding Analysis
CME’s Progress Projection
The Zacks Consensus Estimate for CME Group’s 2025 earnings per share (EPS) signifies an 8.4% year-over-year improve. The consensus estimate for revenues is pegged at $6.53 billion, implying a year-over-year enchancment of 6.5%.
The consensus estimate for 2026 EPS and revenues signifies a rise of 4.3% and 4.9%, respectively, from the corresponding 2025 estimates.
Optimistic Analyst Sentiment for CME
Two of the ten analysts masking the inventory have raised estimates for 2025, and two analysts have raised the identical for 2026 over the previous 30 days. Thus, the Zacks Consensus Estimate for 2025 and 2026 earnings has moved north 0.08% and 0.3%, respectively, previously 30 days.
Goal Worth Displays Potential Upside
Primarily based on short-term worth targets supplied by 16 analysts, the Zacks common worth goal is $291.38 per share. The typical signifies a possible 6.4% upside from the final closing worth.
Picture Supply: Zacks Funding Analysis
Components Impacting CME
CME Group demonstrates sturdy natural progress. On condition that CME is an change, it naturally advantages from heightened market volatility, which fuels buying and selling exercise and, in flip, will increase clearing and transaction charges. These charges proceed to be the most important contributor to CME’s prime line, and their sustained progress bodes effectively for future income growth.
CME Group can be seeing rising digital buying and selling exercise and growing traction in crypto belongings, pushed by rising participation within the broader crypto economic system. With Donald Trump’s second time period ushering in a extra crypto-friendly regulatory local weather, CME is well-positioned to capitalize on these developments.
CME’s investments are delivering constructive returns, and its ongoing give attention to value effectivity helps to enhance margins. A strong capital base helps initiatives to develop its market knowledge enterprise, broaden its product vary and pursue strategic capital deployment.
Furthermore, CME has constantly delivered sturdy monetary efficiency, with free money circulation conversion exceeding 85% in latest quarters — a testomony to its strong earnings high quality.
Finish Notes
A powerful international presence, a compelling product portfolio, a strong capital place and a give attention to over-the-counter clearing companies poise CME effectively for progress. A crypto-friendly regulatory local weather will add to the upside.
CME’s dividend historical past is spectacular, too. It pays 5 dividends per 12 months, with the fifth being variable and based mostly on extra money circulation, making it a horny decide for yield-seeking traders.
Its strong progress projection, engaging valuation, and constructive analyst assertion are different positives. The inventory presently carries a Zacks Rank #3 (Maintain). You may see the entire listing of right this moment’s Zacks #1 Rank (Sturdy Purchase) shares right here.
Zacks Naming Prime 10 Shares for 2026
Wish to be tipped off early to our 10 prime picks for the whole lot of 2026? Historical past suggests their efficiency could possibly be sensational.
From 2012 (when our Director of Analysis Sheraz Mian assumed accountability for the portfolio) by way of November, 2025, the Zacks Prime 10 Shares gained +2,530.8%, greater than QUADRUPLING the S&P 500’s +570.3%.
Now Sheraz is combing by way of 4,400 firms to handpick the very best 10 tickers to purchase and maintain in 2026. Don’t miss your likelihood to get in on these shares after they’re launched on January 5.
Be First to New Prime 10 Shares >>
Intercontinental Trade Inc. (ICE) : Free Inventory Evaluation Report
CME Group Inc. (CME) : Free Inventory Evaluation Report
OTC Markets Group Inc. (OTCM) : Free Inventory Evaluation Report
S&P World Inc. (SPGI) : Free Inventory Evaluation Report
This text initially printed on Zacks Funding Analysis (zacks.com).
The views and opinions expressed herein are the views and opinions of the writer and don’t essentially mirror these of Nasdaq, Inc.
